Victrex (LON:VCT) Shares Down 8.4% - Should You Sell?

Victrex plc (LON:VCT - Get Free Report)'s share price traded down 8.4% during trading on Tuesday . The company traded as low as GBX 667.62 ($9.01) and last traded at GBX 720 ($9.71). 827,259 shares traded hands during trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.60).

Analyst Upgrades and Downgrades

VCT has been the subject of several recent research reports. JPMorgan Chase & Co. dropped their price target on Victrex from GBX 940 ($12.68) to GBX 818 ($11.03) and set a "neutral" rating for the company in a research report on Wednesday. Deutsche Bank Aktiengesellschaft downgraded shares of Victrex to a "hold" rating and reduced their price target for the stock from GBX 990 ($13.35) to GBX 850 ($11.47) in a research note on Tuesday.

Victrex Trading Down 0.5%

The company has a debt-to-equity ratio of 10.93, a quick ratio of 1.99 and a current ratio of 4.39. The company has a market cap of £631.91 million, a price-to-earnings ratio of 20.58, a P/E/G ratio of 1.92 and a beta of 0.69. The company's fifty day moving average is GBX 793.01 and its two-hundred day moving average is GBX 888.34.

Victrex (LON:VCT - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.30) EPS for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. On average, research analysts anticipate that Victrex plc will post 73.1078905 EPS for the current year.

Insider Activity at Victrex

In other news, insider David Thomas purchased 1,158 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average cost of GBX 846 ($11.41) per share, with a total value of £9,796.68 ($13,215.54). Also, insider Dame Vivienne Cox purchased 2,747 shares of Victrex stock in a transaction that occurred on Tuesday, July 8th. The stock was acquired at an average cost of GBX 721 ($9.73) per share, with a total value of £19,805.87 ($26,717.75). Corporate insiders own 1.64% of the company's stock.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.